Thyroid Cancer Genomics - Cancer PHGKB -

Specific PHGKB|Cancer|PHGKB

Thyroid Cancer Genomics

- Cancer PHGKB -

What's New

Last Posted: Mar 07, 2019

---

• Appropriate Management of Attenuated Familial Adenomatous Polyposis: Report of a Case and Review of the Literature.  
  Sokic-Milutinovic Aleksandra et al. Digestive diseases (Basel, Switzerland) 2019 Mar 1-6
• Can current molecular tests help in the diagnosis of indeterminate thyroid nodule FNAB?  
  Ferraz Carolina et al. Archives of endocrinology and metabolism 2018 62(6) 576-584
• Patient quality of life and prognosis in multiple endocrine neoplasia type 2.  
  Grey Joanna et al. Endocrine-related cancer 2018 25(2) T69-T77
• Diagnostic yield and clinical utility of a comprehensive gene panel for hereditary tumor syndromes.  
  Henn Jonas et al. Hereditary cancer in clinical practice 2019 175
• Molecular Testing for Oncogenic Gene Alterations in Pediatric Thyroid Lesions.  
  Mostoufi-Moab Sogol et al. Thyroid : official journal of the American Thyroid Association 2018 28(1) 60-67
• High-accuracy Detection of Preoperative Thyroid Nodules Using Combination of BRAF V600E Mutation and TMPRSS4 mRNA Level.  
  Zhang Yanfang et al. Archives of medical research 2018 Dec
• Do patients with familial nonmedullary thyroid cancer present with more aggressive disease? Implications for initial surgical treatment.  
  El Lakis Mustapha et al. Surgery 2018 Oct
• When should genetic testing be performed in patients with neuroendocrine tumours?  
  O'Shea Triona et al. Reviews in endocrine & metabolic disorders 2017 18(4) 499-515
• Circulating tumour DNA is a potential biomarker for disease progression and response to targeted therapy in advanced thyroid cancer.  
  Allin D M et al. European journal of cancer (Oxford, England : 1990) 2018 Sep 103165-175
• Management of Individuals at Increased Hereditary Risk  
  ASCO, 2018
• Methylation markers differentiate thyroid cancer from benign nodules.  
  Stephen J K et al. Journal of endocrinological investigation 2018 Feb 41(2) 163-170
• THYROSEQ ® V2.0 MOLECULAR TESTING: A COST-EFFECTIVE APPROACH FOR THE EVALUATION OF INDETERMINATE THYROID NODULES.  
  Rivas Ana Marcella et al. Endocrine practice : official journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists 2018 Aug
• Next-Generation Sequencing Identifies a Highly Accurate miRNA Panel That Distinguishes Well-Differentiated Thyroid Cancer from Benign Thyroid Nodules.  
  Mazeh Haggi et al. Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology 2018 Jul
• The role of TERT promoter mutations in postoperative and preoperative diagnosis and prognosis in thyroid cancer.  
  Jin Anqi et al. Medicine 2018 Jul 97(29) e11548
• Diagnostic value and lymph node metastasis prediction of a custom‑made panel (thyroline) in thyroid cancer.  
  Ke Zunfu et al. Oncology reports 2018 Jun